| A Quarter-Century of HIV/AIDS: Its Neuropsychiatric and Neurologic Aspects | | At the completion of this session, the participant should be able to: | 1) | Understand the changes in prevalence and treatment of HIV-1-associated neurocognitive disorders since the beginning of the epidemic; | 2) | Understand the changes in prevalence and treatment of neurologic disorders with psychiatric manifestations (e.g. distal sensory polyneuropathy, progressive multifocal leukoencephalopathy, and CVA risk) | 3) | Understand the impact of these disorders on functional status in HIV-1 infection | 4) | Understand the impact of these disorders with immunologic and virologic measures of HIV-1 disease progession | | |
|
| |
